• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊维菌素:药理学及其在皮肤病学中的应用

Ivermectin: pharmacology and application in dermatology.

作者信息

Dourmishev Assen L, Dourmishev Lyubomir A, Schwartz Robert A

机构信息

Department of Dermatology and Venereology, Medical University, Sofia, Bulgaria.

出版信息

Int J Dermatol. 2005 Dec;44(12):981-8. doi: 10.1111/j.1365-4632.2004.02253.x.

DOI:10.1111/j.1365-4632.2004.02253.x
PMID:16409259
Abstract

Ivermectin is a synthetic derivative of the antiparasitic class of compounds known as avermectins. It is a macrolide endectocide with activity against both endoparasites with cutaneous tropism (Strongyloides stercoralis, Ancylostoma braziliense, Cochliomyia hominivorax, Dermatobia hominis, Filaria bancrofti, Wucheria malayi, Onchocerca volvulus, Loa-loa) and ectoparasites such as Sarcoptes scabies, Pediculus humanus, Demodex folliculorum, and Cheyletiella sp. Ivermectin is of great interest in the treatment of patients with different forms of scabies, head lice, demodecidosis, cutaneous larva migrans, cutaneous larva currens, myiasis, and filariasis.

摘要

伊维菌素是一种被称为阿维菌素的抗寄生虫类化合物的合成衍生物。它是一种大环内酯类体内外寄生虫杀虫剂,对具有皮肤嗜性的体内寄生虫(粪类圆线虫、巴西钩虫、人皮蝇、人肤蝇、班氏丝虫、马来布鲁线虫、盘尾丝虫、罗阿丝虫)和体外寄生虫如疥螨、人虱、毛囊蠕形螨和犬小孢子菌均有活性。伊维菌素在治疗不同类型的疥疮、头虱、毛囊蠕形螨病、皮肤幼虫移行症、匐行疹、蝇蛆病和丝虫病患者方面具有重要意义。

相似文献

1
Ivermectin: pharmacology and application in dermatology.伊维菌素:药理学及其在皮肤病学中的应用
Int J Dermatol. 2005 Dec;44(12):981-8. doi: 10.1111/j.1365-4632.2004.02253.x.
2
Ivermectin in dermatology.伊维菌素在皮肤病学中的应用
J Drugs Dermatol. 2003 Jan;2(1):13-21.
3
[Ivermectin].
Med Trop (Mars). 2005;65(1):69-79.
4
[Ivermectin].[伊维菌素]
Ann Dermatol Venereol. 2004 Jun-Jul;131(6-7 Pt 1):561-70. doi: 10.1016/s0151-9638(04)93668-x.
5
[Ivermectin and tropical dermatoses].[伊维菌素与热带皮肤病]
Bull Soc Pathol Exot. 1997;90(1):37-8.
6
Treatment of oral myiasis caused by Cochliomyia hominivorax: two cases treated with ivermectin.嗜人锥蝇引起的口腔蝇蛆病的治疗:两例使用伊维菌素治疗的病例
Br J Oral Maxillofac Surg. 2009 Jan;47(1):23-6. doi: 10.1016/j.bjoms.2008.04.009. Epub 2008 Jun 2.
7
Role of ivermectin in the treatment of severe orbital myiasis due to Cochliomyia hominivorax.伊维菌素在治疗由嗜人锥蝇引起的严重眼眶蝇蛆病中的作用。
Clin Infect Dis. 2006 Sep 15;43(6):e57-9. doi: 10.1086/507038. Epub 2006 Aug 8.
8
Ivermectin: uses and impact 20 years on.伊维菌素:20年的使用情况及影响
Curr Opin Infect Dis. 2006 Dec;19(6):588-93. doi: 10.1097/QCO.0b013e328010774c.
9
[New indications of ivermectin].[伊维菌素的新适应症]
Rev Med Interne. 2001 Apr;22(4):379-84. doi: 10.1016/s0248-8663(01)00350-2.
10
Oral ivermectin for the treatment and prophylaxis of scabies in prison.口服伊维菌素用于监狱疥疮的治疗和预防。
J Dermatolog Treat. 2005 Aug;16(3):138-41. doi: 10.1080/09546630510041277.

引用本文的文献

1
Is systemic ivermectin as effective as topical ivermectin in eliminating Demodex mites?全身性伊维菌素在消除蠕形螨方面与局部用伊维菌素一样有效吗?
Arch Dermatol Res. 2025 Jan 16;317(1):257. doi: 10.1007/s00403-024-03777-5.
2
Demodex and the eye - A review.蠕形螨与眼睛——综述
Indian J Ophthalmol. 2025 Jan 1;73(1):10-18. doi: 10.4103/IJO.IJO_1591_24. Epub 2024 Dec 23.
3
Die-off reaction of mites after treating demodicosis with oral ivermectin: A case report.口服伊维菌素治疗蠕形螨病后螨的死亡反应:一例报告
JAAD Case Rep. 2024 Jul 26;52:1-3. doi: 10.1016/j.jdcr.2024.07.006. eCollection 2024 Oct.
4
Development and validation of ivermectin quantification method in volumetric absorptive microsampling using liquid chromatography-tandem mass spectrometry.使用液相色谱-串联质谱法在体积吸收微采样中进行伊维菌素定量方法的开发与验证
Heliyon. 2024 Apr 15;10(8):e29606. doi: 10.1016/j.heliyon.2024.e29606. eCollection 2024 Apr 30.
5
Rosacea: Pathogenesis and Therapeutic Correlates.酒渣鼻:发病机制与治疗相关性。
J Cutan Med Surg. 2024 Mar-Apr;28(2):178-189. doi: 10.1177/12034754241229365. Epub 2024 Mar 7.
6
Fatal Disseminated Strongyloidiasis in an Immunosuppressed Patient During COVID-19 Pandemic.COVID-19 大流行期间免疫抑制患者的致命性播散性旋毛虫病。
Acta Parasitol. 2023 Sep;68(3):711-717. doi: 10.1007/s11686-023-00705-x. Epub 2023 Aug 2.
7
Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19.抗寄生虫药物伊维菌素用于治疗和/或预防2019冠状病毒病的潜在新用途。
Pharmaceuticals (Basel). 2022 Aug 27;15(9):1068. doi: 10.3390/ph15091068.
8
Successful treatment of ivermectin refractory demodicosis with isotretinoin and permethrin cream.异维A酸和氯菊酯乳膏成功治疗伊维菌素难治性蠕形螨病
JAAD Case Rep. 2022 Jul 1;26:98-100. doi: 10.1016/j.jdcr.2022.06.017. eCollection 2022 Aug.
9
Ivermectin for preventing and treating COVID-19.伊维菌素预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3.
10
Bullous Scabies in an Immunocompromised Host.免疫功能低下宿主的大疱性疥疮
Case Rep Infect Dis. 2022 Mar 28;2022:3797745. doi: 10.1155/2022/3797745. eCollection 2022.